View Author
patient psoriasis treatment therapy study evidence ciclosporin dermatol guideline effect table response disease methotrexate infection grade dermatology combination infliximab plaque psoriasis psoriasis vulgaris etanercept efalizumab european efficacy pasi 75 response vulgari 12 weeks result author reaction adalimumab phototherapy level suppl arthritis liver jeadv improvement group academy venereology compilation journal increase 5–70 venereology guidelines pregnancy trial plaque side effects pasi /bsa arthritis venereology pathirana measure symptom interaction acitretin malignancy contraindication reduction quality © 2009 assessment retinoid serum safety pasi 75 erythema blood 5 mg /kg randomized alefacept exposure induction therapy hepatitis tuberculosis fumaric acid esters recommendation maintenance month
2 Most Recent Publications
|
How good are clinical severity and outcome measures for psoriasis: Quantitative evaluation in a systematic review
(Article)
Spuls, P.I. Lecluse, L.L.A. Poulsen, M.L.N.F. Bos, J.D. Stern, R.S. Nijsten, T.E.C. |
2010-04-01
|
|
European S3-guidelines on the systemic treatment of psoriasis vulgaris
(Article)
Pathirana, D. Ormerod, A.D. Dubertret, L. Eberlein, B. Erdmann, R. Ferguson, J. Girolomoni, G. Gisondi, P. Giunta, A. Griffiths, C.E.M. Hönigsmann, H. Hussain, M. Saiag, P. Jobling, R. Karvonen, S.L. Kemeny, L. Kopp, I. Leonardi, C. MacCarone, M. Menter, A. Mrowietz, U. Naldi, L. Nijsten, T.E.C. Smith, C. Ortonne, J.P. Orzechowski, H.D. Rantanen, T. Reich, K. Reytan, N. Richards, H. Thio, H.B. Kerkhof, P.C.M. van de Rzany, B. Spuls, P.I. Nast, A. Barker, J. Bos, J.D. Burmester, G.R. Chimenti, S. |
2009-10-01
|